UP!

EMR $113.45

EMR target price
113.45
0
120
Emerson Electric
Type
Public
Traded as
  • NYSE: EMR
  • S&P 100 component
  • S&P 500 component
Industry Electrical equipment
Predecessor Emerson Electric Manufacturing Co.
Founded 1890; 127 years ago (1890)
Founder John W. Emerson
Headquarters Ferguson, Missouri, U.S.
Area served
Worldwide
Key people
David N. Farr (Chairman & CEO)
Products Process control systems
Climate technologies
Power technologies
Industrial automation
Electric motors
Storage systems
Network power
Professional tools
Revenue Decrease $22.304 billion (2015)
Net income
Increase $2.710 billion (2015)
Total assets Decrease $22.088 billion (2015)
Total equity Decrease $8.128 billion (2015)
Number of employees
111,000 (2015)
Divisions List of business platforms
Website Emerson.com

The Emerson Electric Company (NYSE: EMR) is an American multinational corporation headquartered in Ferguson, Missouri, United States. This Fortune 500 company manufactures products and provides engineering services for a wide range of industrial, commercial, and consumer markets. Emerson has approximately 103,500 employees and 205 manufacturing locations worldwide.

Emerson was established in 1890 in St. Louis, Missouri as Emerson Electric Manufacturing Co. by Civil War Union veteran John Wesley Emerson to manufacture electric motors using a patent owned by the Scottish-born brothers Charles and Alexander Meston. In 1892, it became the first to sell electric fans in the United States. It quickly expanded its product line to include electric sewing machines, electric dental drills, and power tools.

During World War II, under the leadership of Stuart Symington, Emerson became the world's largest manufacturer of airplane armament. Emerson ranked 52nd among United States corporations in the value of World War II military production contracts. Symington went on to become the first United States Secretary of the Air Force from 1947-1950, a Democratic U.S. Senator from Missouri from 1953-1976, and a candidate for the Presidency of the United States in 1960.

In 1954, W.R. "Buck" Persons was named company president. Under his leadership, Emerson diversified its business portfolio by acquiring 36 companies. When he retired in 1973, the company had 82 plants, 31,000 employees and $800 million in sales.

In 1962, acquired United States Electrical Manufacturing Company as the U.S. Electrical Motors Division, including the brand U.S. MOTORS®.

Charles F. Knight served as CEO from 1973 to 2000, and was chairman from 1974 to 2004. His tenure was marked by development of a rigorous planning process, new product and technology development, acquisitions and joint ventures, and international growth.

David Farr has served as CEO since 2000 and as chairman since 2004.

On December 15, 1999, Emerson Electric Co, moving to boost its growth prospects, agreed to acquire Jordan Industries Inc's telecommunications equipment business for $440 million.

In 2010, U.S. MOTORS® brand sold to Nidec Motor Corporation.

On July 26, 2011, Emerson announced it would locate its Latin America headquarters in Sunrise, Florida.

On December 1, 2016, Platinum Equity acquired Emerson Network Power business unit and rebranded it Vertiv. The acquisition included the brands: Asco, Chloride, Liebert, Netsure, and Trellis.

The company's leaders since the mid-20th century have been, respectively, W. R. Persons (1954-1973; President), Charles Knight (1973-2000, CEO), and David Farr (2000 forward, CEO).

The company's chairmen of the board have been, respectively, Charles Knight (1974-2004) and David Farr (2004 forward).

As of 2014, the role of chief marketing officer was held by Kathy Button Bell.

Emerson is structured into 2 business platforms:

Researchers at the University of Massachusetts (MA) Amherst have identified Emerson as the 97th largest corporate producer of air pollution in the United States, down from its previous rank of 56th. Major pollutants indicated by the study include nickel compounds, manganese, diisocyanate, and lead.

On December 22, 2014 Emerson announced the acquisition of Scotland-based Cascade Technologies Ltd., expanding their gas-analysis portfolio with laser-based measurement analyzers and systems for enhanced industrial emissions monitoring, production efficiencies and regulatory compliance. Other main Emerson acquisitions and brands include:

On October 2, 2006, Emerson filed suit in federal court against NBC regarding a scene that appeared in the pilot episode of the network's TV series Heroes. The scene depicted Claire Bennet reaching into an active garbage disposal, severely injuring her hand. Emerson's suit claims the scene "casts the disposer in an unsavory light, irreparably tarnishing the product" by suggesting that serious injuries will result "in the event consumers were to accidentally insert their hand into one."

Emerson asked for a ruling barring future broadcasts of the pilot and to block NBC from using any Emerson trademarks in the future.

On February 23, 2007, the case was dropped. NBC Universal and Emerson Electric settled the lawsuit outside of court.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2023 2023-02-08 Future report Set alerts
Q4 2022 2022-10-31 1.53 1.53
Q3 2022 2022-08-09 1.38 1.38
Q2 2022 2022-05-04 1.29 1.29
Q1 2022 2022-02-02 1.05 1.05
Q4 2021 2021-11-03 1.21 1.21
Q3 2021 2021-08-04 1.09 1.09
Q2 2021 2021-05-05 0.97 0.97
Q1 2021 2021-02-02 0.83 0.83
Q4 2020 2020-11-03 1.10 1.10

Ratings

2016-07-10 Reiterated Rating Credit Suisse Group AG Buy
2016-06-27 Reiterated Rating Sanford C. Bernstein Market Perform
2016-06-27 Reiterated Rating Robert W. Baird Neutral $58.00
2016-06-22 Reiterated Rating Bank of America Sell
2016-06-22 Reiterated Rating Oppenheimer Hold
2016-06-22 Reiterated Rating Bank of America Corp. Sell
2016-06-22 Reiterated Rating Oppenheimer Holdings Inc. Hold
2016-05-11 Upgrade Argus Hold to Buy $61.00
2016-05-09 Boost Price Target Deutsche Bank Hold $44.00 to $55.00
2016-05-09 Boost Price Target Deutsche Bank AG Hold $44.00 to $55.00
2016-05-05 Reiterated Rating Credit Suisse Buy
2016-05-05 Reiterated Rating Credit Suisse Group AG Buy
2016-05-04 Downgrade Vertical Research Hold to Sell
2016-05-04 Boost Price Target RBC Capital Sector Perform $47.00 to $50.00
2016-05-04 Lower Price Target Stifel Nicolaus Buy $61.00 to $60.00
2016-05-04 Boost Price Target Royal Bank Of Canada Sector Perform $47.00 to $50.00
2016-04-19 Reiterated Rating Citigroup Inc. Sell $41.00 to $49.00
2016-04-18 Boost Price Target Barclays Equal Weight $47.00 to $54.00
2016-04-18 Boost Price Target Barclays PLC Equal Weight $47.00 to $54.00
2016-04-07 Boost Price Target Morgan Stanley $48.00 to $50.00
2016-03-14 Boost Price Target Credit Suisse Outperform $54.00 to $55.00
2016-02-29 Downgrade Standpoint Research Buy to Hold
2016-02-13 Reiterated Rating Deutsche Bank Hold
2016-02-09 Reiterated Rating Oppenheimer Market Perform
2016-02-03 Lower Price Target Robert W. Baird Neutral $55.00 to $49.00
2016-02-03 Boost Price Target Stifel Nicolaus Buy $50.00 to $51.00
2016-02-03 Lower Price Target Societe Generale Hold $52.00 to $49.00
2016-02-03 Lower Price Target Credit Suisse Outperform $54.00 to $53.00
2016-02-03 Reiterated Rating William Blair Market Perform $50.00
2016-02-03 Reiterated Rating Canaccord Genuity Hold $48.00
2016-01-21 Initiated Coverage Citigroup Inc. Sell $41.00
2016-01-20 Upgrade Standpoint Research Hold to Buy
2016-01-19 Boost Price Target Barclays Equal Weight $46.00 to $47.00
2016-01-12 Reiterated Rating Nomura Buy $60.00
2016-01-12 Reiterated Rating Nomura Holdings Inc. Buy $60.00
2015-12-14 Lower Price Target Credit Suisse Outperform $55.00 to $54.00
2015-11-10 Lower Price Target Deutsche Bank Hold $46.00 to $44.00
2015-11-05 Downgrade Societe Generale Buy to Hold $56.00 to $52.00
2015-11-04 Boost Price Target Stifel Nicolaus Buy $51.00 to $56.00
2015-11-04 Reiterated Rating Canaccord Genuity Hold $52.00
2015-11-04 Lower Price Target RBC Capital Sector Perform $49.00 to $47.00
2015-10-07 Lower Price Target Nomura Buy $63.00 to $59.00
2015-10-07 Lower Price Target Morgan Stanley $55.00 to $50.00
2015-10-05 Lower Price Target Barclays Equal Weight $53.00 to $46.00
2015-09-23 Lower Price Target Societe Generale Buy $61.00 to $56.00
2015-09-21 Lower Price Target RBC Capital $50.00 to $49.00
2015-09-18 Lower Price Target Credit Suisse Outperform $57.00 to $55.00
2015-09-08 Initiated Coverage Sterne Agee CRT Neutral $44.00
2015-09-03 Downgrade Goldman Sachs Neutral to Sell $49.00 to $42.00
2015-09-03 Downgrade Goldman Sachs Group Inc. Neutral to Sell $49.00 to $42.00
2015-08-31 Reiterated Rating Oppenheimer Hold
2015-08-26 Upgrade Vertical Research Hold to Buy
2015-08-25 Reiterated Rating Deutsche Bank Hold $53.00
2015-08-06 Downgrade Argus Buy to Hold
2015-08-05 Reiterated Rating Cowen and Company Market Perform $59.00 to $52.00
2015-08-05 Lower Price Target Barclays Equal Weight $54.00 to $53.00
2015-08-05 Reiterated Rating Canaccord Genuity Hold $62.00 to $52.00
2015-08-05 Lower Price Target Stifel Nicolaus Buy $60.00 to $57.00
2015-08-05 Lower Price Target RBC Capital Sector Perform $57.00 to $50.00
2015-07-13 Lower Price Target Barclays Equal Weight $55.00 to $54.00
2015-06-26 Lower Price Target Morgan Stanley Equal Weight $59.00
2015-06-26 Lower Price Target JPMorgan Chase & Co. Neutral $55.00 to $54.00
2015-06-23 Boost Price Target Robert W. Baird Neutral $58.00 to $59.00
2015-06-01 Reiterated Rating JPMorgan Chase & Co. Neutral $56.00 to $55.00
2015-05-22 Boost Price Target Stifel Nicolaus Buy $63.00 to $66.00
2015-05-12 Reiterated Rating JPMorgan Chase & Co. Neutral $58.00 to $56.00
2015-05-09 Reiterated Rating Societe Generale Buy $71.00 to $68.00
2015-05-06 Lower Price Target RBC Capital Sector Perform $58.00 to $56.00
2015-05-06 Lower Price Target Barclays Equal Weight $61.00 to $55.00
2015-05-06 Lower Price Target Canaccord Genuity Hold $65.00 to $62.00
2015-04-27 Lower Price Target RBC Capital Sector Perform $60.00 to $58.00
2015-04-27 Lower Price Target Barclays Equal Weight $63.00 to $61.00
2015-03-17 Lower Price Target Barclays Equal Weight $66.00 to $63.00
2015-02-20 Reiterated Rating Canaccord Genuity Hold $65.00
2015-02-20 Boost Price Target Stifel Nicolaus Buy $64.00 to $66.00
2015-02-10 Lower Price Target Argus Buy $75.00 to $70.00
2015-02-09 Downgrade Atlantic Securities Overweight to Neutral $74.00 to $59.00
2015-02-09 Downgrade Oppenheimer Outperform to Market Perform
2015-02-06 Lower Price Target JPMorgan Chase & Co. Neutral $62.00 to $58.00
2015-02-04 Lower Price Target Bank of America $56.00
2015-01-30 Reiterated Rating Canaccord Genuity Hold $65.00
2015-01-29 Lower Price Target Nomura Buy $74.00 to $67.00
2015-01-22 Downgrade Robert W. Baird Outperform to Neutral $74.00 to $65.00
2015-01-22 Downgrade Bank of America Neutral to Underperform $66.00 to $62.00
2015-01-21 Reiterated Rating Stifel Nicolaus Buy $77.00 to $69.00
2015-01-15 Lower Price Target JPMorgan Chase & Co. Neutral $67.00 to $62.00
2015-01-12 Lower Price Target Barclays Equal Weight $67.00 to $66.00
2014-12-17 Downgrade Credit Agricole Outperform to Underperform
2014-12-17 Downgrade Credit Agricole SA Outperform to Underperform
2014-12-12 Downgrade Deutsche Bank Buy to Hold $68.00
2014-12-05 Lower Price Target Bank of America Neutral $68.00 to $66.00
2014-11-24 Initiated Coverage RBC Capital Sector Perform $69.00
2014-11-05 Reiterated Stifel Buy $74 to $77
2014-11-05 Reiterated Rating Nomura Buy $76.00 to $74.00
2014-11-05 Boost Price Target Stifel Nicolaus Buy $74.00 to $77.00
2014-10-29 Downgrade Wells Fargo & Co. Outperform to Market Perform
2014-10-29 Downgrade Wells Fargo Outperform to Market Perform
2014-09-16 Initiated Coverage Stifel Nicolaus Buy $81.00
2014-09-12 Boost Price Target JPMorgan Chase & Co. $69.00 to $73.00
2014-09-09 Initiated Coverage Societe Generale Buy
2014-09-05 Initiated Coverage Buckingham Research Neutral $67.00
2014-08-08 Lower Price Target JPMorgan Chase & Co. $72.00 to $69.00
2014-08-06 Reiterated Rating Nomura Buy $84.00 to $76.00
2014-08-06 Lower Price Target Morgan Stanley $69.00 to $68.00
2014-08-06 Lower Price Target Oppenheimer Outperform $77.00 to $70.00
2014-07-11 Upgrade Argus Hold to Buy $75.00
2014-05-07 Reiterated Rating Morgan Stanley Equal Weight $68.00 to $69.00
2014-04-11 Boost Price Target Robert W. Baird Outperform $75.00 to $79.00
2014-03-21 Upgrade Oppenheimer Market Perform to Outperform $77.00
2014-02-18 Boost Price Target FBR & Co. Market Perform $60.00 to $65.00
2013-11-20 Reiterated Rating Credit Suisse Buy $73.00
2013-11-20 Boost Price Target Sanford C. Bernstein Market Perform $68.00 to $71.00
2013-11-07 Boost Price Target MKM Partners Neutral $60.00 to $71.00
2013-11-06 Boost Price Target Credit Suisse Outperform $68.00 to $73.00
2013-11-06 Boost Price Target Barclays Equal Weight $60.00 to $65.00
2013-10-07 Boost Price Target Barclays Equal Weight $56.00 to $60.00
2013-02-07 Reiterated MKM Partners Neutral $52 to $56
2012-05-02 Reiterated FBR Capital Mkt Perform $54 to $51
2012-03-15 Reiterated Oppenheimer Outperform $58 to $61
2011-09-28 Initiated MKM Partners Neutral $47
2011-08-30 Downgrade Argus Buy to Hold
2011-05-04 Reiterated Oppenheimer Outperform $74 to $71
2011-04-27 Upgrade Oppenheimer Perform to Outperform $65 to $74
2016-07-10 Reiterated Rating Credit Suisse Group AG Buy
2016-06-27 Reiterated Rating Sanford C. Bernstein Market Perform
2016-06-27 Reiterated Rating Robert W. Baird Neutral $58.00
2016-06-22 Reiterated Rating Bank of America Sell
2016-06-22 Reiterated Rating Oppenheimer Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
FARR DAVID N Chairman of Board & CEO 0.26%  (1837991) EMR / IBM /
PETERS CHARLES A Sr. Exec. VP 0.11%  (787790) EMR /
GALVIN WALTER J Vice Chairman 0.05%  (331456) AEE / AEGN / EMR /
BUSCH AUGUST A III 0.04%  (251731) EMR /
MONSER EDWARD L President & COO 0.03%  (217810) APD / EMR /
DELLAQUILA FRANK J Sr. VP & CFO 0.03%  (186643) DLPH / EMR /
ASHMORE CRAIG W Exec. VP - Planning & Develop. 0.03%  (183259) EMR /
Purvis Edgar M Jr Exec. Vice President and COO 0.02%  (158984) EMR / HSC /
STEEVES FRANK L Exec. VP, Secy & Gen. Counsel 0.02%  (151888) EMR /
Train Michael H. Exec. Pres. Auto. Sols. 0.02%  (144491) EMR /
Bulanda Mark J VP-Acquisitions & Development 0.02%  (115847) EMR /
Sharp Robert T Exec. Pres. Comm & Res. Sols. 0.01%  (95823) EMR /
SCHLUETER RICHARD J VP, Contr. & Chief Acc. Off. 0.01%  (84946) EMR /
Pelch Steve J. VP - Organizational Planning 0.01%  (80617) EMR /
GOLDEN ARTHUR F 0.01%  (69147) EMR /
Fernandez Gonzalez Carlos 0.01%  (67427) EMR /
Bosco Sara Yang Sr. VP, Secy and Gen. Counsel 0.01%  (43914) EMR /
STEPHENSON RANDALL L 0.01%  (40449) BA / EMR / T /
PRUEHER JOSEPH W 0.01%  (39033) AHH / EMR / FLR /
Button Bell Katherine Sr. VP & Chief Marketing Off. 0.01%  (36839) EMR /
RIDGWAY ROZANNE L 0.01%  (35647) EMR /